Kiniksa Pharmaceuticals International, plc (KNSA) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2017: $17.43M2018: $42.70M2019: $29.11M2020: $37.53M2021: $47.76M2022: $63.52M2023: $87.48M2024: $142.12M2025: $196.03M$196.03M
2017Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$196.03M+37.9%
2024$142.12M+62.5%
2023$87.48M+37.7%
2022$63.52M+33.0%
2021$47.76M+27.3%
2020$37.53M+28.9%
2019$29.11M-31.8%
2018$42.70M+145.0%
2017$17.43M